162 related articles for article (PubMed ID: 29030149)
1. Clinical management of women presenting with field effect of HPV and intraepithelial disease.
Adams TS; Mbatani NH
Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():86-94. PubMed ID: 29030149
[TBL] [Abstract][Full Text] [Related]
2. Management of atypical squamous cells, low-grade squamous intraepithelial lesions, and cervical intraepithelial neoplasia 1.
Boardman LA; Kennedy CM
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):599-614; ix. PubMed ID: 19061819
[TBL] [Abstract][Full Text] [Related]
3. Have we resolved how to triage equivocal cervical cytology?
Solomon D; Schiffman M
J Natl Cancer Inst; 2004 Feb; 96(4):250-1. PubMed ID: 14970266
[No Abstract] [Full Text] [Related]
4. [Not Available].
Bode-Lesniewska B; Caduff R
Praxis (Bern 1994); 2017; 106(6):305-310. PubMed ID: 28300000
[No Abstract] [Full Text] [Related]
5. [Molecular diagnosis of HPV infections].
Wentzensen N
Pathologe; 2011 Nov; 32(6):461-6. PubMed ID: 21845360
[TBL] [Abstract][Full Text] [Related]
6. [Intraepithelial lesions and neoplasia associated with human papillomavirus infection].
Riethmuller D; Guerrini JS; Aubin F
Bull Acad Natl Med; 2007 Mar; 191(3):601-9; discussion 609. PubMed ID: 18072656
[TBL] [Abstract][Full Text] [Related]
7. Chapter 17: Genital human papillomavirus infections--current and prospective therapies.
Stanley M
J Natl Cancer Inst Monogr; 2003; (31):117-24. PubMed ID: 12807955
[TBL] [Abstract][Full Text] [Related]
8. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
J Gynecol Oncol; 2018 Jan; 29(1):e8. PubMed ID: 29185266
[TBL] [Abstract][Full Text] [Related]
9. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
[TBL] [Abstract][Full Text] [Related]
10. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors.
American College of Obstetricians and Gynecologists
Obstet Gynecol; 2013 Dec; 122(6):1338-67. PubMed ID: 24264713
[No Abstract] [Full Text] [Related]
11. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
Jiang MY; Wu Z; Li T; Yu L; Zhang SK; Zhang X; Qu P; Sun P; Xi MR; Liu X; Liao G; Sun L; Zhang Y; Chen W; Qiao YL
Cancer Prev Res (Phila); 2020 Feb; 13(2):163-172. PubMed ID: 31871224
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
[TBL] [Abstract][Full Text] [Related]
13. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
14. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile.
Hampl M; Wentzensen N; Vinokurova S; von Knebel-Doeberitz M; Poremba C; Bender HG; Kueppers V
J Cancer Res Clin Oncol; 2007 Apr; 133(4):235-45. PubMed ID: 17294241
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Betschart C; Ghisu GP; Fink D
Praxis (Bern 1994); 2016 Nov; 105(23):1363-1369. PubMed ID: 27854170
[No Abstract] [Full Text] [Related]
17. [Role of high-risk human papillomavirus testing in the screening and management of cervical cancer precursors].
Jin Y; Pan LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):691-6. PubMed ID: 18051730
[TBL] [Abstract][Full Text] [Related]
18. Human telomerase gene and high-risk human papillomavirus infection are related to cervical intraepithelial neoplasia.
Zhao XY; Cui Y; Jiang SF; Liu KJ; Han HQ; Liu XS; Li Y
Asian Pac J Cancer Prev; 2015; 16(2):693-7. PubMed ID: 25684510
[TBL] [Abstract][Full Text] [Related]
19. Preventing cervical cancer globally by acting locally: if not now, when?
Gage JC; Castle PE
J Natl Cancer Inst; 2010 Oct; 102(20):1524-7. PubMed ID: 20884892
[No Abstract] [Full Text] [Related]
20. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.
Plummer M; Schiffman M; Castle PE; Maucort-Boulch D; Wheeler CM;
J Infect Dis; 2007 Jun; 195(11):1582-9. PubMed ID: 17471427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
